TSWM
ABBV icon

Triangle Securities Wealth Management’s AbbVie ABBV Stock Holding History

Triangle Securities Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,267
Closed -$201K – 152
2019
Q4 		$201K Buy
+2,267
New +$188K 0.09% 161
2013
Q3 		– Sell
-628
Closed -$26K – 121
2013
Q2 		$26K Buy
+628
New +$27.5K 0.02% 341

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Triangle Securities Wealth Management's ABBV Position: Q1 2020 in Review

Triangle Securities Wealth Management sold out of AbbVie (ABBV) in Q1 2020, closing a stake of 2,267 shares — an estimated $201K sold.

Triangle Securities Wealth Management first reported a position in ABBV in Q2 2013 and held it in 2 quarters. The position peaked at $201K in Q4 2019. 2,225 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

  • Triangle Securities Wealth Management reported no remaining AbbVie position as of Q1 2020 after selling out during the quarter.
  • Triangle Securities Wealth Management sold 2,267 AbbVie shares in Q1 2020, an estimated $201K.
  • Triangle Securities Wealth Management first reported a position in AbbVie in Q2 2013 and held it in 2 quarters.
  • Triangle Securities Wealth Management's AbbVie position peaked at $201K in Q4 2019.
  • 2,225 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on Triangle Securities Wealth Management's 13F filing for Q1 2020, filed 6 Apr 2020.